Medeon Biodesign, Inc. announced board changes. Title and name of the previous position holder: Director - Hong Jen Chang, Director - Hsin Yuan Fang, Independent Director - Jerome Shen. Resume of the previous position holder: Hong Jen Chang: Chairman and CEO, YFY Biotech Management Company.

Hsin Yuan Fang:Vice Superintendent of Department of Surgery, China Medical University Hospital. Jerome Shen:Chairman of Taiwania Capital Biotechnology Corporation. Title and name of the new position holder: Independent Director - Feng Shyang Yang.

Resume of the new position holder: Feng Shyang Yang:Supervisor, Adimmune Corporation. Reason for the change: Term expired. Effective date of the new appointment is June 12, 2024.

Original term is from July 16, 2021 to July 15, 2024.